Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srishti Chakravorty

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|November 17, 2022
EBV-associated diseases: Current therapeutics and emerging technologiesSrishti Chakravorty, Behdad Afzali, Majid Kazemian
Molecular Cancer Therapeutics|December 2, 2025
Immune reprogramming of tumor microenvironments by cytotoxic antibody-drug conjugate payloadsSrishti Chakravorty, Yulia Zybina, Eunseon Ahn, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactualBingyu Yan, Srishti Chakravorty, Carmen Mirabelli, et al.
Journal of Virology|May 13, 2021
Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and ArtifactualBingyu Yan, Srishti Chakravorty, Carmen Mirabelli, et al.
Cancer Research|September 5, 2019
Integrated Pan-Cancer Map of EBV-Associated Neoplasms Reveals Functional Host-Virus InteractionsSrishti Chakravorty, Bingyu Yan, Chong Wang, et al.
JCI Insight|August 19, 2020
Granzyme A-producing T helper cells are critical for acute graft-versus-host diseaseSungtae Park, Brad Griesenauer, Hua Jiang, et al.
Journal of Medical Virology|December 1, 2022
A comprehensive single cell data analysis of lymphoblastoid cells reveals the role of super-enhancers in maintaining EBV latencyBingyu Yan, Chong Wang, Srishti Chakravorty, et al.
Journal for Immunotherapy of Cancer|August 19, 2025
Pharmacological and structural characterization of vibostolimab, a novel anti-TIGIT blocking antibody for cancer immunotherapyThierry O Fischmann, Daniel Malashock, Eunseon Ahn, et al.
Nature Communications|August 23, 2024
Unbiased discovery of cancer pathways and therapeutics using Pathway Ensemble Tool and BenchmarkLuopin Wang, Aryamav Pattnaik, Subhransu Sekhar Sahoo, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|November 17, 2022
EBV-associated diseases: Current therapeutics and emerging technologiesSrishti Chakravorty, Behdad Afzali, Majid Kazemian
Molecular Cancer Therapeutics|December 2, 2025
Immune reprogramming of tumor microenvironments by cytotoxic antibody-drug conjugate payloadsSrishti Chakravorty, Yulia Zybina, Eunseon Ahn, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactualBingyu Yan, Srishti Chakravorty, Carmen Mirabelli, et al.
Journal of Virology|May 13, 2021
Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and ArtifactualBingyu Yan, Srishti Chakravorty, Carmen Mirabelli, et al.
Cancer Research|September 5, 2019
Integrated Pan-Cancer Map of EBV-Associated Neoplasms Reveals Functional Host-Virus InteractionsSrishti Chakravorty, Bingyu Yan, Chong Wang, et al.
JCI Insight|August 19, 2020
Granzyme A-producing T helper cells are critical for acute graft-versus-host diseaseSungtae Park, Brad Griesenauer, Hua Jiang, et al.
Journal of Medical Virology|December 1, 2022
A comprehensive single cell data analysis of lymphoblastoid cells reveals the role of super-enhancers in maintaining EBV latencyBingyu Yan, Chong Wang, Srishti Chakravorty, et al.
Journal for Immunotherapy of Cancer|August 19, 2025
Pharmacological and structural characterization of vibostolimab, a novel anti-TIGIT blocking antibody for cancer immunotherapyThierry O Fischmann, Daniel Malashock, Eunseon Ahn, et al.
Nature Communications|August 23, 2024
Unbiased discovery of cancer pathways and therapeutics using Pathway Ensemble Tool and BenchmarkLuopin Wang, Aryamav Pattnaik, Subhransu Sekhar Sahoo, et al.
Pageof 1